{
    "Title": "A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model",
    "URL": "https://doi.org/10.1371/journal.pntd.0000913",
    "Published": "December 7, 2010",
    "Subject_Areas": [
        "Lipids",
        "Vitamins",
        "Gastrointestinal tract",
        "Mouse models",
        "Leishmaniasis",
        "Parasitic diseases",
        "Emulsions",
        "Fluids"
    ],
    "Authors": {
        "Ellen K. Wasan": [
            "School of Health Sciences, British Columbia Institute of Technology, Burnaby, Canada"
        ],
        "Pavel Gershkovich": [
            "Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada"
        ],
        "Jinying Zhao": [
            "Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada"
        ],
        "Xiaohua Zhu": [
            "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America"
        ],
        "Karl Werbovetz": [
            "Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, United States of America"
        ],
        "Richard R. Tidwell": [
            "Department of Pathology and Lab Medicine, Consortium for Parasitic Drug Development, University of North Carolina, Chapel Hill, North Carolina, United States of America"
        ],
        "John G. Clement": [
            "iCo Therapeutics Inc., Vancouver, Canada"
        ],
        "Sheila J. Thornton": [
            "Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada"
        ],
        "Kishor M. Wasan": [
            "Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada"
        ]
    }
}